Nursing Care Study Guide – Learning Objectives

Ch. 38 Endocrine System

1. Identify the glands of the endocrine system:

a. Pituitary gland (anterior and posterior)
b. Thyroid gland
c. Parathyroid glands
d. Adrenal glands (cortex and medulla)
e. Pancreas (Islets of Langerhans)
f. Pineal gland
g. Thymus
h. Gonads (ovaries and testes)
2. Explain the function of each of the hormones in the endocrine system:
a. Pituitary Gland:
i. Anterior: Produces hormones like Growth Hormone (GH), Thyroid
Stimulating Hormone (TSH), Adrenocorticotropic Hormone (ACTH),
and more, regulating other glands.
ii. Posterior: Stores and releases oxytocin and antidiuretic hormone
(ADH).
b. Thyroid Gland: Secretes thyroxine (T4) and triiodothyronine (T3) which
regulate metabolism, and calcitonin which helps regulate calcium levels.
c. Parathyroid Glands: Secrete parathyroid hormone (PTH) to regulate calcium
and phosphorus metabolism.
d. Adrenal Glands:
i. Cortex: Secretes corticosteroids (e.g., cortisol) and aldosterone,
managing stress, metabolism, and blood pressure.
ii. Medulla: Produces catecholamines (epinephrine and norepinephrine)
that mediate fight-or-flight response.
e. Pancreas: Produces insulin and glucagon to regulate blood sugar levels.
f. Pineal Gland: Secretes melatonin, influencing sleep-wake cycles.
g. Thymus: Releases thymosins, involved in T-cell development for immune
function.
h. Gonads: Ovaries produce estrogen and progesterone; testes produce
testosterone, regulating reproductive function.
3. Describe the effects of aging on endocrine system function:
 a. Decreased hormone production (e.g., GH, estrogen, testosterone, T3, and
T4).
b. Slower metabolism, leading to weight gain and decreased energy.
c. Reduced stress response due to lower cortisol levels.
d. Decreased insulin sensitivity, possibly leading to increased risk of type 2
diabetes.
e. Thymus shrinks with age, decreasing immune function.
4. List data to collect when caring for a patient with a disorder of the endocrine
system:
a. Health History: Symptoms such as fatigue, weight changes, temperature
intolerance, mood swings, or changes in skin, hair, and nails.
b. Medications: Current and past treatments for hormonal disorders.
c. Physical Assessment: Blood pressure, heart rate, weight, skin texture, and
other signs of glandular dysfunction.
d. Lab Values: Hormone levels (e.g., TSH, cortisol, insulin, glucose), electrolyte
levels (e.g., calcium), and diagnostic imaging results.
e. Patient Education: Understanding of their condition, adherence to
medications, and monitoring for signs of hormone imbalance.
5. Plan nursing care for patients undergoing testing for an endocrine disorder:
a. Pre-test Care: Ensure patient is informed and prepared (e.g., fasting for
blood tests or imaging studies).
b. Monitor for Adverse Reactions: If contrast dyes are used, assess for allergic
reactions.
c. Post-test Care: Monitor vital signs, and assess for symptoms of
hypo/hyperglycemia or other hormone fluctuations.
d. Patient Education: Explain test results, and provide guidance on any
necessary lifestyle or medication adjustments.
e. Support: Address patient concerns and manage any anxiety related to
testing and diagnosis.

Ch. 39 Endocrine Disorders by Gland and Their Management:

1. Pituitary Gland Disorders:

• Disorders:
o Acromegaly/Gigantism: Caused by excess Growth Hormone (GH).
Acromegaly occurs in adults, while gigantism occurs in children.
 o Diabetes Insipidus (DI): Deficiency of Antidiuretic Hormone (ADH), leading
to excessive urine output and dehydration.
o SIADH (Syndrome of Inappropriate ADH secretion): Excess ADH, causing
water retention and hyponatremia.
• Pathophysiology:
o Acromegaly/Gigantism: Hypersecretion of GH causes abnormal bone
growth, especially in hands, feet, and face.
o Diabetes Insipidus: Insufficient ADH prevents the kidneys from retaining
water, leading to excessive urination.
o SIADH: Excess ADH causes kidneys to retain water, diluting blood sodium
levels.
• Etiologies, Signs, and Symptoms:
o Acromegaly/Gigantism: Usually caused by pituitary tumors; symptoms
include enlarged hands/feet, coarse facial features, and joint pain.
o DI: Can result from head injury, surgery, or genetic defects. Symptoms
include excessive thirst, dehydration, and large amounts of dilute urine.
o SIADH: Often due to malignancies, lung diseases, or head trauma.
Symptoms include confusion, seizures, and low sodium levels.
• Therapeutic Measures:
o Acromegaly: Surgery to remove tumor, radiation, or medication (e.g.,
somatostatin analogs).
o DI: ADH replacement (desmopressin) and fluid management.
o SIADH: Fluid restriction, hypertonic saline, and medications like vasopressin
receptor antagonists.
• Data to Collect:
o Fluid balance, weight changes, urine output, serum electrolytes (especially
sodium), and hormone levels (GH, ADH).
• Nursing Care Plan:
o Monitor fluid balance (I&O), electrolyte levels, neurological status, and
symptoms of hormone imbalance. Educate on medication adherence and
dietary modifications.
• Evaluation of Effectiveness:
o Normalization of hormone levels, balanced fluid and electrolyte status,
resolution of symptoms like polyuria (in DI) or hyponatremia (in SIADH).
2. Thyroid Gland Disorders:

• Disorders:
o Hypothyroidism (e.g., Hashimoto’s Disease): Deficiency of thyroid
hormones (T3 and T4).
o Hyperthyroidism (e.g., Grave’s Disease): Excess thyroid hormone
production.
o Goiter: Enlargement of the thyroid gland, often due to iodine deficiency.
• Pathophysiology:
o Hypothyroidism: Decreased production of T3 and T4, slowing metabolism.
o Hyperthyroidism: Overproduction of thyroid hormones increases metabolic
rate.
o Goiter: Enlargement can occur due to iodine deficiency or thyroid
dysfunction.
• Etiologies, Signs, and Symptoms:
o Hypothyroidism: Often autoimmune (Hashimoto’s). Symptoms include
fatigue, weight gain, cold intolerance, dry skin, and bradycardia.
o Hyperthyroidism: Commonly autoimmune (Grave’s). Symptoms include
weight loss, heat intolerance, tachycardia, and exophthalmos (bulging eyes).
o Goiter: May result from iodine deficiency, autoimmune disease, or hormonal
imbalances. Symptoms include visible neck swelling and respiratory
difficulty.
• Therapeutic Measures:
o Hypothyroidism: Thyroid hormone replacement therapy (levothyroxine).
o Hyperthyroidism: Antithyroid medications (e.g., methimazole), radioactive
iodine therapy, or thyroidectomy.
o Goiter: Iodine supplementation, thyroid hormone replacement, or surgery in
severe cases.
• Data to Collect:
o TSH, T3, and T4 levels, weight, heart rate, body temperature, and patient’s
energy levels.
• Nursing Care Plan:
o Monitor thyroid function tests, vital signs, and signs of thyroid storm
(hyperthyroidism) or myxedema coma (hypothyroidism). Educate on
medication adherence, follow-up, and dietary needs (especially iodine
intake).
• Evaluation of Effectiveness:
 o Normalized TSH, T3, and T4 levels, improvement in energy, stable weight,
and resolution of symptoms like palpitations or fatigue.

3. Parathyroid Gland Disorders:

• Disorders:
o Hyperparathyroidism: Excess parathyroid hormone (PTH) secretion, leading
to hypercalcemia.
o Hypoparathyroidism: Deficiency of PTH, leading to hypocalcemia.
• Pathophysiology:
o Hyperparathyroidism: Overproduction of PTH leads to excess calcium
being released from bones into the bloodstream, increasing blood calcium
levels.
o Hypoparathyroidism: Decreased PTH causes insufficient calcium in the
blood and increased phosphorus levels.
• Etiologies, Signs, and Symptoms:
o Hyperparathyroidism: Often caused by parathyroid tumors. Symptoms
include bone pain, kidney stones, muscle weakness, and fatigue.
o Hypoparathyroidism: Can result from thyroid surgery or autoimmune
disease. Symptoms include muscle cramps, tetany, and seizures.
• Therapeutic Measures:
o Hyperparathyroidism: Surgical removal of the parathyroid gland(s),
medications to lower calcium levels.
o Hypoparathyroidism: Calcium and vitamin D supplements, PTH injections
in severe cases.
• Data to Collect:
o Serum calcium, phosphorus, and PTH levels, bone density scans, and renal
function tests.
• Nursing Care Plan:
o Monitor for signs of hypo/hypercalcemia, ensure safe mobility to prevent
fractures, and educate on diet high in calcium and vitamin D or low in
calcium as needed.
• Evaluation of Effectiveness:
o Stabilized calcium and PTH levels, prevention of fractures, and absence of
kidney stones or tetany.
4. Adrenal Gland Disorders:

• Disorders:
o Cushing’s Syndrome: Excess cortisol production.
o Addison’s Disease: Insufficient cortisol and aldosterone production.
o Pheochromocytoma: Tumor of the adrenal medulla causing excess
catecholamine (epinephrine and norepinephrine) production.
• Pathophysiology:
o Cushing’s Syndrome: Overproduction of cortisol leads to hyperglycemia,
weight gain, and immunosuppression.
o Addison’s Disease: Adrenal insufficiency causes low cortisol and
aldosterone, leading to hypotension, dehydration, and electrolyte
imbalances.
o Pheochromocytoma: Excess catecholamine release causes severe
hypertension and episodes of palpitations, sweating, and headaches.
• Etiologies, Signs, and Symptoms:
o Cushing’s: Often caused by adrenal tumors or prolonged steroid use.
Symptoms include moon face, buffalo hump, hyperglycemia, and muscle
weakness.
o Addison’s: Autoimmune destruction of the adrenal glands or infections.
Symptoms include fatigue, weight loss, hyperpigmentation, and low blood
pressure.
o Pheochromocytoma: Usually caused by a benign adrenal tumor. Symptoms
include episodic hypertension, palpitations, and anxiety.
• Therapeutic Measures:
o Cushing’s: Surgery to remove tumors, tapering off steroids, or medications
to block cortisol production.
o Addison’s: Cortisol replacement (hydrocortisone) and aldosterone
replacement (fludrocortisone).
o Pheochromocytoma: Surgical removal of the tumor, blood pressure
management with alpha-blockers or beta-blockers.
• Data to Collect:
o Cortisol levels, blood glucose, blood pressure, and signs of adrenal crisis (in
Addison’s).
• Nursing Care Plan:
 o Monitor blood pressure, glucose levels, electrolyte balance, and provide
education on medication adherence and stress management for Addison’s
patients.
• Evaluation of Effectiveness:
o Stabilized cortisol levels, normal blood pressure and glucose, absence of
adrenal crisis or hypertensive episodes.

Acromegaly/Gigantism:

• Pathophysiology: Overproduction of Growth Hormone (GH), usually due to a

benign pituitary adenoma. In gigantism (occurs in children), GH excess before the
closure of growth plates leads to increased height. In acromegaly (in adults), excess
GH after growth plates close causes bone thickening rather than elongation,
especially in hands, feet, and face.
• Etiologies: Pituitary adenomas (tumors) are the primary cause of excessive GH.
• Signs and Symptoms:
o Enlarged hands, feet, and facial bones (especially jaw and forehead).
o Joint pain and thickened skin.
o Deepened voice (due to vocal cord thickening).
o In gigantism: abnormally tall stature with proportional growth.

B. Diabetes Insipidus (DI):

• Pathophysiology: Deficiency of Antidiuretic Hormone (ADH) or resistance to ADH

in the kidneys, leading to excessive water loss through urine (polyuria) and inability
to concentrate urine.
• Etiologies: Head trauma, pituitary surgery, genetic factors, or kidney resistance
(nephrogenic DI).
• Signs and Symptoms:
o Excessive thirst (polydipsia) and frequent urination (polyuria).
o Dilute urine and dehydration.
o Low blood pressure and dry skin.
C. Syndrome of Inappropriate Antidiuretic Hormone (SIADH):

• Pathophysiology: Excessive release of ADH causes the kidneys to retain water,

leading to water retention, dilutional hyponatremia (low sodium levels), and fluid
imbalance.
• Etiologies: Head trauma, lung disease (e.g., pneumonia, tuberculosis),
malignancies (especially small cell lung cancer), or medications.
• Signs and Symptoms:
o Confusion, headache, seizures (due to low sodium levels).
o Low urine output despite adequate fluid intake.
o Weight gain without visible edema.

2. Thyroid Gland Disorders:

A. Hypothyroidism (e.g., Hashimoto’s Thyroiditis):

• Pathophysiology: Insufficient production of thyroid hormones (T3 and T4), leading

to decreased metabolic rate. This can be due to autoimmune destruction of the
thyroid gland (as in Hashimoto’s disease) or iodine deficiency.
• Etiologies: Autoimmune (Hashimoto’s disease), iodine deficiency, thyroid surgery,
radiation therapy, or medications (e.g., lithium).
• Signs and Symptoms:
o Fatigue, weight gain, cold intolerance, and constipation.
o Bradycardia, dry skin, hair loss, and muscle weakness.
o Myxedema (severe, untreated hypothyroidism) causing swelling of tissues.

B. Hyperthyroidism (e.g., Grave’s Disease):

• Pathophysiology: Overproduction of thyroid hormones (T3 and T4), leading to an

increased metabolic rate. This is often due to autoimmune activation of the thyroid
gland in Grave’s disease.
• Etiologies: Autoimmune disease (Grave’s disease), thyroid nodules, or excessive
iodine intake.
• Signs and Symptoms:
o Weight loss, heat intolerance, and increased appetite.
o Tachycardia, palpitations, tremors, and anxiety.
 o Exophthalmos (bulging eyes, especially in Grave’s disease), and goiter
(enlarged thyroid).

C. Goiter:

• Pathophysiology: Enlargement of the thyroid gland due to overstimulation (as in

iodine deficiency, hyperthyroidism) or structural changes (nodular goiter).
• Etiologies: Iodine deficiency, autoimmune diseases (Grave’s or Hashimoto’s), or
thyroid nodules.
• Signs and Symptoms:
o Visible swelling in the neck.
o Difficulty breathing or swallowing (if the goiter is large).
o Symptoms associated with either hyperthyroidism or hypothyroidism,
depending on the underlying cause.

3. Parathyroid Gland Disorders:

A. Hyperparathyroidism:

• Pathophysiology: Excess secretion of parathyroid hormone (PTH) causes elevated

calcium levels (hypercalcemia) by stimulating calcium release from bones,
increasing calcium reabsorption in the kidneys, and enhancing calcium absorption
in the intestines.
• Etiologies: Parathyroid adenomas (primary hyperparathyroidism), chronic kidney
disease (secondary hyperparathyroidism), or vitamin D deficiency.
• Signs and Symptoms:
o Bone pain, fractures, and osteoporosis.
o Kidney stones and excessive urination.
o Muscle weakness, fatigue, and constipation.
o Psychiatric symptoms such as depression and confusion.

B. Hypoparathyroidism:

• Pathophysiology: Insufficient secretion of PTH leads to hypocalcemia (low calcium

levels) and hyperphosphatemia (high phosphate levels), resulting in neuromuscular
excitability and tetany.
 • Etiologies: Most commonly due to accidental damage or removal of the parathyroid
glands during thyroid surgery, autoimmune disease, or genetic conditions.
• Signs and Symptoms:
o Muscle cramps, tingling, and numbness (especially in fingers, toes, and
around the mouth).
o Tetany (involuntary muscle contractions), seizures, and laryngospasm.
o Positive Chvostek’s and Trousseau’s signs (hypocalcemia signs).

4. Adrenal Gland Disorders:

A. Cushing’s Syndrome:

• Pathophysiology: Excess cortisol production, typically due to adrenal tumors,

long-term use of corticosteroid medications, or ACTH-secreting tumors. Excess
cortisol disrupts metabolism, leading to hyperglycemia, protein breakdown, and fat
redistribution.
• Etiologies: Prolonged corticosteroid use (iatrogenic), adrenal or pituitary tumors
(Cushing’s disease), or ectopic ACTH production from non-endocrine tumors.
• Signs and Symptoms:
o Weight gain, particularly around the abdomen, face (moon face), and back
(buffalo hump).
o Thin skin, easy bruising, and purple striae (stretch marks).
o Muscle weakness, osteoporosis, and hyperglycemia.
o Hypertension, mood swings, and increased risk of infections.

B. Addison’s Disease:

• Pathophysiology: Insufficient production of cortisol and aldosterone due to

adrenal gland destruction (primary adrenal insufficiency). This leads to an inability
to maintain blood pressure, blood glucose, and electrolyte balance.
• Etiologies: Autoimmune destruction of adrenal glands (most common), infections
(e.g., tuberculosis), or adrenal hemorrhage.
• Signs and Symptoms:
o Fatigue, weight loss, and muscle weakness.
o Hyperpigmentation of skin (especially in pressure points and mucous
membranes).
o Hypotension, salt cravings, and dehydration.
 o Symptoms of adrenal crisis include severe hypotension, confusion, and
shock.

C. Pheochromocytoma:

• Pathophysiology: A tumor of the adrenal medulla causes excessive production of

catecholamines (epinephrine and norepinephrine), leading to episodic
hypertension and sympathetic nervous system overactivity.
• Etiologies: Benign adrenal medulla tumors; familial genetic syndromes like
Multiple Endocrine Neoplasia (MEN).
• Signs and Symptoms:
o Episodic hypertension, palpitations, sweating, and severe headaches.
o Anxiety, tremors, and chest pain.
o Episodes triggered by physical activity or stress.

Pituitary Gland Disorders:

A. Acromegaly/Gigantism

• Therapeutic Measures:
o Surgical removal of pituitary tumor: Preferred treatment for acromegaly
and gigantism if caused by a tumor.
o Medications: Somatostatin analogs (e.g., octreotide), dopamine agonists,
and GH receptor antagonists can reduce GH levels.
o Radiation therapy: Used if surgery is not possible or to reduce tumor size
post-surgery.
• Data to Collect:
o Growth hormone (GH) levels.
o Size of the pituitary tumor (from imaging like MRI or CT scan).
o Symptoms: changes in hand/foot size, joint pain, and fatigue.
o Postoperative complications: cerebrospinal fluid leaks or infections.
• Nursing Care Plan:
o Preoperative: Educate patient on surgical procedure and postoperative
expectations.
o Postoperative: Monitor neurological function, vital signs, and signs of
increased intracranial pressure.
 o Administer prescribed medications and monitor for side effects.
o Assess for changes in physical features and symptoms of hormone
imbalance.
• Evaluation of Effectiveness:
o GH levels return to normal.
o Improvement or stabilization of symptoms like joint pain and soft tissue
enlargement.
o No new signs of hormone excess (e.g., facial feature changes).

B. Diabetes Insipidus (DI)

• Therapeutic Measures:
o Desmopressin (DDAVP): Synthetic ADH replacement to control urine
output.
o Fluid replacement therapy: To prevent dehydration.
o Thiazide diuretics: In nephrogenic DI, to reduce urine output.
• Data to Collect:
o Daily fluid intake/output and urine specific gravity.
o Serum sodium levels and osmolality.
o Signs of dehydration or fluid overload.
• Nursing Care Plan:
o Monitor for signs of dehydration and administer IV fluids as needed.
o Educate the patient about medication use and importance of staying
hydrated.
o Assess for electrolyte imbalances, particularly hypernatremia.
• Evaluation of Effectiveness:
o Stabilization of fluid balance (normal urine output).
o Resolution of symptoms like excessive thirst and dehydration.
o Normal serum sodium levels and urine osmolality.

C. Syndrome of Inappropriate ADH Secretion (SIADH)

• Therapeutic Measures:
o Fluid restriction: First-line treatment to manage water retention.
o Hypertonic saline: For severe hyponatremia.
 o Medications: Vasopressin receptor antagonists (e.g., tolvaptan) to block
ADH action.
• Data to Collect:
o Daily weight and fluid balance.
o Serum sodium levels and osmolality.
o Urine output and specific gravity.
• Nursing Care Plan:
o Implement and monitor fluid restriction as ordered.
o Monitor for signs of hyponatremia (e.g., confusion, seizures).
o Educate on the importance of fluid restriction and regular lab tests.
• Evaluation of Effectiveness:
o Normalization of serum sodium levels.
o Improved mental status and resolution of hyponatremia-related symptoms.
o Adequate urine output without fluid overload.

2. Thyroid Gland Disorders:

A. Hypothyroidism (e.g., Hashimoto’s Disease)

• Therapeutic Measures:
o Levothyroxine (synthetic T4): Lifelong thyroid hormone replacement
therapy.
o Regular monitoring of thyroid hormone levels (TSH, T4) to adjust dosage.
• Data to Collect:
o Thyroid hormone levels (TSH, T4).
o Weight, heart rate, and temperature.
o Symptoms: fatigue, cold intolerance, and changes in skin/hair.
• Nursing Care Plan:
o Educate the patient about lifelong medication adherence.
o Monitor for signs of medication overdose (hyperthyroidism symptoms like
palpitations).
o Encourage regular follow-up blood tests to adjust medication dosage.
• Evaluation of Effectiveness:
o Normalization of thyroid hormone levels (TSH and T4).
o Resolution of symptoms like fatigue and cold intolerance.
o Stable weight and improved energy levels.
B. Hyperthyroidism (e.g., Grave’s Disease)

• Therapeutic Measures:
o Antithyroid medications (e.g., methimazole) to reduce hormone
production.
o Radioactive iodine therapy: Destroys overactive thyroid tissue.
o Surgery: Thyroidectomy for severe or unresponsive cases.
• Data to Collect:
o Thyroid hormone levels (TSH, T3, T4).
o Heart rate, weight, and temperature.
o Symptoms: tremors, anxiety, palpitations.
• Nursing Care Plan:
o Monitor for thyroid storm (a life-threatening complication of
hyperthyroidism).
o Educate the patient on medication adherence and potential side effects.
o Post-radioactive iodine: Monitor for hypothyroidism.
• Evaluation of Effectiveness:
o Normalized thyroid hormone levels.
o Resolution of symptoms like palpitations, weight loss, and heat intolerance.
o Improved cardiovascular function.

C. Goiter

• Therapeutic Measures:
o Iodine supplementation for iodine deficiency-related goiter.
o Thyroid hormone replacement to suppress TSH and shrink the goiter.
o Surgery if goiter causes compressive symptoms (difficulty
swallowing/breathing).
• Data to Collect:
o Thyroid function tests (TSH, T3, T4).
o Neck circumference and respiratory status.
o Swallowing difficulties and voice changes.
• Nursing Care Plan:
o Educate on the importance of adequate iodine intake.
o Post-surgical care: Monitor for signs of hypothyroidism or surgical
complications (e.g., vocal cord damage).
• Evaluation of Effectiveness:
 o Shrinking of goiter and improvement in breathing/swallowing.
o Normalized thyroid function tests.

3. Parathyroid Gland Disorders:

A. Hyperparathyroidism

• Therapeutic Measures:
o Surgical removal of overactive parathyroid gland.
o Medications: Calcimimetics to reduce calcium levels, bisphosphonates to
prevent bone loss.
o Adequate hydration to prevent kidney stones.
• Data to Collect:
o Serum calcium, PTH, and phosphorus levels.
o Bone density tests.
o Signs of hypercalcemia (fatigue, muscle weakness).
• Nursing Care Plan:
o Monitor for complications such as kidney stones and fractures.
o Educate the patient about maintaining hydration and taking medications as
prescribed.
• Evaluation of Effectiveness:
o Normalization of serum calcium and PTH levels.
o Improved bone density and absence of hypercalcemia symptoms.

B. Hypoparathyroidism

• Therapeutic Measures:
o Calcium and vitamin D supplementation to maintain calcium levels.
o PTH injections in severe cases.
• Data to Collect:
o Serum calcium and phosphorus levels.
o Neuromuscular symptoms: muscle cramps, tetany, seizures.
• Nursing Care Plan:
o Monitor for signs of hypocalcemia (e.g., Chvostek’s and Trousseau’s signs).
o Educate the patient on the importance of calcium and vitamin D
supplementation.
 • Evaluation of Effectiveness:
o Stabilization of serum calcium levels.
o Absence of hypocalcemia symptoms such as muscle cramps and tetany.

4. Adrenal Gland Disorders:

A. Cushing’s Syndrome

• Therapeutic Measures:
o Surgery: Removal of adrenal or pituitary tumors.
o Medications: To block cortisol production (e.g., ketoconazole, metyrapone).
o Tapering off corticosteroids if iatrogenic Cushing’s.
• Data to Collect:
o Cortisol levels (blood, urine).
o Blood glucose, weight, and blood pressure.
o Symptoms: muscle weakness, fat redistribution, infections.
• Nursing Care Plan:
o Monitor for signs of infection, skin breakdown, and hyperglycemia.
o Educate on tapering steroids safely (if iatrogenic) and maintaining a healthy
lifestyle.
• Evaluation of Effectiveness:
o Normalization of cortisol levels and reduction in symptoms.
o Improved muscle strength and blood glucose control.

B. Addison’s Disease

• Therapeutic Measures:
o Corticosteroid replacement therapy (hydrocortisone) and
mineralocorticoid replacement (fludrocortisone).
o Increased steroid doses during stress (illness, surgery) to prevent adrenal
crisis.
• Data to Collect:
o Serum cortisol and electrolyte levels (sodium, potassium).
o Blood pressure, weight, and energy levels.
o Signs of adrenal crisis (severe hypotension, shock).
• Nursing Care Plan:
 o Educate the patient on lifelong steroid replacement and recognizing adrenal
crisis.
o Monitor for signs of medication overdose (e.g., Cushing’s symptoms) or
underdosing (e.g., fatigue, hypotension).
• Evaluation of Effectiveness:
o Stabilization of blood pressure, electrolyte balance, and energy levels.
o Absence of adrenal crisis.

C. Pheochromocytoma

• Therapeutic Measures:
o Surgery: Removal of adrenal tumor.
o Medications: Alpha-blockers and beta-blockers pre-surgery to control blood
pressure.
• Data to Collect:
o Blood pressure readings, heart rate, and catecholamine levels.
o Symptoms of hypertensive crisis (headache, palpitations, sweating).
• Nursing Care Plan:
o Preoperative: Monitor blood pressure and administer medications to control
hypertension.
o Postoperative: Monitor for blood pressure fluctuations and signs of
catecholamine release.
• Evaluation of Effectiveness:
o Stable blood pressure post-surgery and absence of hypertensive crises.
o Resolution of symptoms like palpitations and headaches.

Explain the Pathophysiologies of Type 1 and Type 2 Diabetes Mellitus:

Type 1 Diabetes Mellitus (T1DM):

• Pathophysiology:
o T1DM is an autoimmune disorder in which the body's immune system
attacks and destroys insulin-producing beta cells in the pancreas. This leads
to an absolute insulin deficiency, meaning the body cannot produce insulin.
Without insulin, glucose cannot enter the cells, leading to elevated blood
glucose (hyperglycemia) and a reliance on external insulin for survival.
Type 2 Diabetes Mellitus (T2DM):

• Pathophysiology:
o T2DM is characterized by insulin resistance, where the body’s cells become
less responsive to insulin. Over time, the pancreas cannot produce enough
insulin to overcome the resistance, leading to relative insulin deficiency and
hyperglycemia. Unlike T1DM, T2DM is often linked to lifestyle factors such as
obesity, inactivity, and poor diet.

2. Identify Risk Factors for Type 1 and Type 2 Diabetes Mellitus:

Risk Factors for T1DM:

• Genetics: Family history of type 1 diabetes.

• Environmental triggers: Viral infections (e.g., enteroviruses), exposure to certain
chemicals or toxins.
• Autoimmune diseases: Co-occurrence with other autoimmune disorders like
Hashimoto’s thyroiditis or celiac disease.

Risk Factors for T2DM:

• Obesity: Particularly abdominal obesity (central adiposity).

• Physical inactivity: Sedentary lifestyle.
• Genetics: Family history of type 2 diabetes.
• Age: Increased risk with advancing age.
• Ethnicity: Higher prevalence in African Americans, Hispanics, Native Americans,
and Pacific Islanders.
• Gestational diabetes history: History of diabetes during pregnancy increases
future risk.
• Poor diet: High intake of processed foods, refined sugars, and low in fiber.

3. Describe the Signs and Symptoms of Diabetes Mellitus:

Common Signs and Symptoms (T1DM and T2DM):

• Polyuria: Frequent urination due to excess glucose in the urine drawing water.
 • Polydipsia: Excessive thirst due to dehydration from frequent urination.
• Polyphagia: Excessive hunger due to the body's inability to utilize glucose.
• Weight loss: Seen more commonly in T1DM as the body breaks down fat and
muscle for energy.
• Fatigue: Due to the inability of cells to utilize glucose for energy.
• Blurred vision: Due to glucose buildup in the lens of the eyes.
• Slow wound healing: Especially in T2DM, due to impaired immune function and
poor circulation.

4. Describe Causes, Signs, and Symptoms, and Treatment of High and

Low Blood Glucose Levels:

Hyperglycemia (High Blood Glucose):

• Causes:
o Inadequate insulin dosage, overeating, stress, illness, or lack of physical
activity.
• Signs and Symptoms:
o Increased thirst, frequent urination, fatigue, blurred vision, headache, and
weight loss.
o In severe cases, it can lead to diabetic ketoacidosis (DKA) in T1DM,
characterized by nausea, vomiting, abdominal pain, and fruity-smelling
breath.
• Treatment:
o Administering insulin (for T1DM) or oral antidiabetic medications (for T2DM).
o Hydration and monitoring blood glucose levels frequently.

Hypoglycemia (Low Blood Glucose):

• Causes:
o Overdose of insulin or oral antidiabetics, skipping meals, excessive alcohol
intake, or intense exercise.
• Signs and Symptoms:
o Sweating, shaking, palpitations, confusion, irritability, dizziness, blurred
vision, and weakness.
 o In severe cases, hypoglycemia can lead to seizures or loss of
consciousness.
• Treatment:
o Immediate intake of fast-acting carbohydrates (e.g., glucose tablets, fruit
juice).
o For severe hypoglycemia, glucagon injection or IV glucose may be required.

5. Discuss How Diabetes Mellitus Increases Risk of Complications Such

as Heart Disease, Blindness, and Kidney Failure:

• Heart Disease:
o Chronic hyperglycemia damages blood vessels, leading to atherosclerosis,
hypertension, and increased risk of coronary artery disease (CAD), stroke,
and peripheral artery disease.
• Blindness (Diabetic Retinopathy):
o Prolonged high blood glucose damages the small blood vessels in the retina,
leading to diabetic retinopathy, macular edema, and, if untreated, blindness.
• Kidney Failure (Diabetic Nephropathy):
o High blood glucose and hypertension damage the nephrons in the kidneys,
reducing kidney function over time, eventually leading to chronic kidney
disease (CKD) and end-stage renal disease (ESRD).
• Other Complications:
o Neuropathy: Damage to nerves, especially in the extremities, causing pain,
numbness, and weakness.
o Foot ulcers and amputations: Poor circulation and neuropathy increase the
risk of foot injuries, infections, and poor wound healing.

6. Identify Diagnostic Tests to Diagnose and Monitor Diabetes Mellitus

and Its Complications:

• Diagnostic Tests for Diabetes:

o Fasting Plasma Glucose (FPG): ≥ 126 mg/dL (7.0 mmol/L) indicates
diabetes.
o Oral Glucose Tolerance Test (OGTT): 2-hour plasma glucose ≥ 200 mg/dL
(11.1 mmol/L) after consuming 75g glucose.
 o Hemoglobin A1c (HbA1c): ≥ 6.5% indicates diabetes. This test shows
average blood glucose levels over the previous 2-3 months.
o Random Plasma Glucose: ≥ 200 mg/dL (11.1 mmol/L) with symptoms of
diabetes.
• Monitoring Tests:
o HbA1c: Regular monitoring (every 3-6 months) to evaluate long-term blood
glucose control.
o Urine tests: For glucose and ketones (for T1DM) and microalbuminuria (to
detect early kidney damage).
o Lipid profile: To assess cholesterol levels and cardiovascular risk.
o Foot exams: Regular assessment for ulcers, calluses, and signs of
neuropathy.
o Eye exams: Yearly screening for diabetic retinopathy.
o Kidney function tests: Serum creatinine, GFR (glomerular filtration rate),
and urine albumin-to-creatinine ratio to monitor kidney health.

Identify Therapeutic Measures to Help Control Blood Glucose Levels in

Diabetes Mellitus:

A. Lifestyle Modifications:

• Dietary management:
o Focus on a balanced diet rich in whole grains, vegetables, lean proteins, and
healthy fats. Patients should monitor carbohydrate intake to control post-
meal blood glucose levels.
o Use of medical nutrition therapy (MNT) tailored to the individual’s needs.
• Exercise:
o Regular physical activity helps improve insulin sensitivity, manage weight,
and lower blood glucose levels. Patients should engage in at least 150
minutes of moderate-intensity exercise weekly.
• Weight management:
o In T2DM, weight loss improves insulin sensitivity, reduces blood glucose
levels, and may reduce the need for medications.

B. Pharmacological Therapy:

• Insulin therapy:
 o Required for T1DM and may be used in T2DM if blood glucose cannot be
controlled with oral medications.
• Oral hypoglycemic agents:
o Used in T2DM to stimulate insulin secretion, increase insulin sensitivity, or
slow carbohydrate absorption.
• Continuous glucose monitoring (CGM):
o Devices that provide real-time data on glucose levels to help individuals
adjust insulin, food intake, and activity.
• Medication adherence:
o Strict adherence to prescribed medications is crucial for maintaining blood
glucose control.

2. Differentiate the Action of Insulin and Oral Hypoglycemic Agents in

Lowering Blood Glucose:

A. Insulin:

• Action:
o Insulin is a hormone that facilitates the uptake of glucose by cells (especially
muscle and fat cells), reducing blood glucose levels. It also inhibits glucose
production by the liver.
• Types:
o Rapid-acting insulin (e.g., lispro, aspart): Acts within minutes, used for
meal-related glucose control.
o Short-acting insulin (e.g., regular insulin): Takes longer to act but lasts
longer than rapid-acting.
o Intermediate-acting insulin (e.g., NPH): Covers blood glucose levels
between meals and during the night.
o Long-acting insulin (e.g., glargine, detemir): Provides a steady level of
insulin over 24 hours.

B. Oral Hypoglycemic Agents:

• Action:
o Biguanides (e.g., metformin): Decrease hepatic glucose production and
increase insulin sensitivity.
 o Sulfonylureas (e.g., glipizide, glyburide): Stimulate the pancreas to secrete
more insulin.
o DPP-4 inhibitors (e.g., sitagliptin): Inhibit the enzyme that degrades incretin
hormones, increasing insulin release.
o SGLT2 inhibitors (e.g., empagliflozin): Increase glucose excretion through
the urine.
o Thiazolidinediones (TZDs) (e.g., pioglitazone): Improve insulin sensitivity in
peripheral tissues.

3. Plan Nursing Care and Education for the Patient with Diabetes Mellitus:

A. Nursing Care:

• Blood glucose monitoring:

o Monitor blood glucose levels regularly, especially before meals and at
bedtime (pre- and post-prandial levels).
• Medication administration:
o Ensure accurate administration of insulin or oral hypoglycemics and monitor
for adverse reactions like hypoglycemia.
• Dietary support:
o Work with dietitians to develop a meal plan tailored to the patient’s lifestyle
and treatment goals.
• Foot care:
o Educate patients on proper foot care to prevent ulcers and infections.
Conduct regular foot inspections for any signs of injury or neuropathy.
• Monitoring for complications:
o Monitor for early signs of diabetic complications such as nephropathy,
retinopathy, and neuropathy.

B. Patient Education:

• Medication management:
o Teach the patient how to administer insulin (if required), store insulin
properly, and take oral medications as prescribed.
• Hypoglycemia prevention:
o Educate on the recognition and management of hypoglycemia (e.g., carrying
glucose tablets or snacks).
 • Diet and exercise:
o Provide guidance on managing carbohydrate intake, portion control, and
incorporating physical activity into daily life.
• Signs of complications:
o Teach patients to recognize symptoms of complications like hyperglycemia,
hypoglycemia, neuropathy, and cardiovascular issues.
• Regular follow-ups:
o Encourage regular appointments with healthcare providers for monitoring
blood glucose levels, kidney function, and eye health.

4. List Measures to Increase Safety of the Patient with Diabetes Mellitus

Undergoing Surgery:

• Preoperative Blood Glucose Control:

o Achieve optimal glycemic control before surgery to reduce the risk of
infection and complications. Preoperative blood glucose levels should be
between 80-180 mg/dL.
• Monitoring Blood Glucose Levels:
o Frequent blood glucose checks during surgery and in the postoperative
period, as stress and surgery may increase glucose levels.
• Insulin and Medication Adjustments:
o Adjust insulin or oral hypoglycemic agents pre- and post-surgery, as the
patient's insulin needs may change. Temporary insulin may be required,
even for patients normally on oral agents.
• Preventing Infection:
o Strict adherence to aseptic techniques during surgery and wound care post-
surgery. Hyperglycemia increases the risk of infection.
• Hydration and Electrolyte Management:
o Maintain adequate hydration and electrolyte balance, as surgery can cause
fluid shifts and affect blood sugar levels.
• Postoperative Wound Care:
o Closely monitor surgical wounds for signs of infection or poor healing,
common in patients with uncontrolled diabetes.
5. Explain Reactive Hypoglycemia and Its Treatment:

A. Reactive Hypoglycemia:

• Definition:
o Reactive hypoglycemia occurs when blood glucose drops too low (usually
below 70 mg/dL) 2-4 hours after a meal. It is typically triggered by an
excessive insulin response following a meal high in carbohydrates.
• Causes:
o Excessive insulin production in response to carbohydrate intake.
o Gastric surgery (dumping syndrome) where food moves too quickly into the
intestines, causing a rapid insulin surge.

B. Signs and Symptoms:

• Shakiness, sweating, anxiety, dizziness, confusion, hunger, weakness, and

palpitations.

C. Treatment:

• Immediate treatment:
o Consuming a fast-acting carbohydrate (e.g., glucose tablets, juice, candy) to
raise blood glucose levels quickly.
• Long-term management:
o Eating small, frequent meals throughout the day.
o Avoiding simple carbohydrates and focusing on complex carbohydrates,
fiber, and protein.
o Avoiding high-sugar foods to prevent rapid blood glucose spikes.
• Monitoring:
o Keeping track of meals and symptoms to identify food triggers and adjust
eating patterns to avoid hypoglycemia episodes.

Describe the Normal Structures and Functions of the Respiratory System:

A. Structures:

1. Upper Respiratory Tract:

 a. Nose and Nasal Cavity: Filters, warms, and humidifies air.
b. Pharynx (Throat): Passageway for air and food.
c. Larynx (Voice Box): Contains vocal cords, involved in sound production and
protects the airway during swallowing.
2. Lower Respiratory Tract:
a. Trachea (Windpipe): Main airway leading to the lungs.
b. Bronchi and Bronchioles: Branching tubes that direct air into the lungs.
c. Lungs:
i. Alveoli: Small air sacs where gas exchange (oxygen and carbon
dioxide) occurs.
ii. Pleura: Membranes surrounding the lungs, with pleural fluid allowing
smooth movement during breathing.

B. Functions:

• Gas Exchange: In the alveoli, oxygen from inhaled air enters the blood, and carbon
dioxide from the blood is exhaled.
• Ventilation: Movement of air into and out of the lungs (inhalation and exhalation).
• Protection: Mucous membranes, cilia, and immune cells help trap and remove
pathogens and debris.
• Acid-Base Balance: The respiratory system helps regulate blood pH by controlling
levels of carbon dioxide.

2. Identify How Aging Affects the Respiratory System:

• Decreased lung elasticity: Lungs become stiffer, reducing their ability to expand
fully.
• Decreased muscle strength: Diaphragm and intercostal muscles weaken, leading
to less effective breathing.
• Reduced ciliary function: Cilia in the airways become less effective at clearing
mucus, increasing infection risk.
• Reduced alveolar surface area: Fewer functional alveoli for gas exchange, leading
to reduced oxygen exchange efficiency.
• Decreased cough reflex: Weakened cough increases the risk of aspiration and
respiratory infections.
3. List Data to Collect When Caring for a Patient with a Respiratory
Disorder:

• Health History:
o Smoking history, exposure to environmental pollutants, or occupational
hazards.
o History of respiratory conditions (asthma, COPD, pneumonia).
o Symptoms such as cough, sputum production, shortness of breath, chest
pain, or wheezing.
• Physical Assessment:
o Respiratory rate, depth, and effort (e.g., use of accessory muscles).
o Oxygen saturation (SpO2) and arterial blood gases (ABG) if available.
o Temperature (to assess for infection).
• Psychosocial Factors:
o Anxiety, fatigue, or impact on daily activities.

4. Recognize Expected Findings When Inspecting, Palpating, Percussing,

and Auscultating the Chest:

A. Inspection:

• Normal Findings: Symmetrical chest expansion, no use of accessory muscles,

relaxed posture.
• Abnormal Findings: Cyanosis, clubbing of fingers (indicates chronic hypoxia),
barrel chest (common in COPD).

B. Palpation:

• Normal Findings: Symmetrical chest wall movement, no tenderness.

• Abnormal Findings: Decreased chest expansion on one side (pneumothorax,
atelectasis), tenderness (indicates pleuritis or injury).

C. Percussion:

• Normal Findings: Resonance over lung fields.

 • Abnormal Findings: Dullness (indicates fluid or consolidation, e.g., pneumonia),
hyperresonance (indicates air trapping, e.g., emphysema).

D. Auscultation:

• Normal Findings: Clear breath sounds (vesicular sounds over most lung fields).
• Abnormal Findings:
o Wheezes (narrowed airways, e.g., asthma or COPD).
o Crackles (rales) (fluid in alveoli, e.g., pneumonia, pulmonary edema).
o Absent breath sounds (e.g., pneumothorax, pleural effusion).

5. Identify Common Diagnostic Tests Performed to Diagnose Disorders of

the Respiratory System:

• Chest X-ray (CXR): Visualizes lung structure, infections, and abnormalities (e.g.,
pneumonia, tumors).
• Pulmonary Function Tests (PFTs): Measure lung capacity, volume, and flow rates
(used to diagnose COPD, asthma).
• Arterial Blood Gas (ABG): Assesses oxygenation, carbon dioxide levels, and acid-
base status.
• Sputum Culture: Identifies pathogens causing infection (e.g., tuberculosis,
bacterial pneumonia).
• CT Scan: Provides detailed images of lung tissues and can detect tumors, blood
clots, or lung diseases.
• Bronchoscopy: Visualizes the airways and allows biopsy or removal of
obstructions.
• Pulse Oximetry: Measures oxygen saturation in the blood.
• Thoracentesis: Procedure to remove pleural fluid for diagnostic analysis (used to
evaluate pleural effusion).

6. Plan Nursing Care for Patients Undergoing Each of the Diagnostic Tests:

• Chest X-ray:
o Pre-care: Explain the procedure, remove any metallic objects from the chest
area.
 o Post-care: No specific care needed unless abnormalities are found.
• Pulmonary Function Tests:
o Pre-care: Ensure the patient avoids bronchodilators or smoking before the
test.
o Post-care: Monitor for dizziness or shortness of breath post-test.
• Arterial Blood Gas:
o Pre-care: Explain the arterial blood draw and the potential discomfort.
o Post-care: Apply pressure to the puncture site to prevent bleeding, monitor
for signs of impaired circulation.
• Sputum Culture:
o Pre-care: Instruct the patient on how to provide a deep sputum sample,
preferably in the morning.
o Post-care: Ensure the specimen is promptly sent to the lab.
• CT Scan:
o Pre-care: Screen for allergies if contrast dye is used, ensure the patient is
NPO if required.
o Post-care: Monitor for allergic reactions to contrast dye if used.
• Bronchoscopy:
o Pre-care: Ensure informed consent, NPO status 6-8 hours before the
procedure.
o Post-care: Monitor for respiratory distress, gag reflex, and bleeding.

7. Discuss Therapeutic Measures Used to Help Patients with Respiratory

Disorders:

A. Medications:

• Bronchodilators: Relax airway muscles (e.g., albuterol, ipratropium) to improve

airflow in asthma or COPD.
• Steroids: Reduce inflammation in the airways (e.g., prednisone, inhaled
corticosteroids like fluticasone).
• Antibiotics: Treat bacterial infections like pneumonia or bronchitis.
• Antitussives: Suppress cough in patients with non-productive coughs.
• Expectorants: Help loosen and clear mucus from the airways (e.g., guaifenesin).
B. Oxygen Therapy:

• Administered via nasal cannula, face mask, or high-flow systems to maintain

adequate oxygen saturation, especially in hypoxic patients (e.g., COPD,
pneumonia).

C. Chest Physiotherapy (CPT):

• Includes postural drainage, percussion, and vibration to help clear mucus from the
lungs in patients with COPD, cystic fibrosis, or bronchiectasis.

D. Mechanical Ventilation:

• Used for patients with severe respiratory failure or during surgery to assist or
replace spontaneous breathing.

E. Smoking Cessation:

• Critical in preventing further lung damage in patients with respiratory conditions.

Education, counseling, and nicotine replacement therapies may be used.

F. Pulmonary Rehabilitation:

• A structured program of exercise, education, and support to improve lung function

and quality of life in patients with chronic respiratory diseases.

Explain the Pathophysiology of Disorders of the Upper Respiratory Tract:

A. Rhinitis (Common Cold, Allergic Rhinitis):

• Pathophysiology: Inflammation of the nasal mucosa due to infection (viral or

bacterial) or allergens. This leads to increased mucus production and vasodilation
of the nasal blood vessels.
• Result: Swelling and congestion of nasal passages, obstruction of airflow, and
increased mucus production.
B. Sinusitis:

• Pathophysiology: Inflammation of the sinuses due to infection, allergies, or

obstruction of the sinus drainage system. This leads to mucus build-up and
pressure in the sinus cavities.
• Result: Sinus congestion, pain, and potential bacterial overgrowth.

C. Pharyngitis (Sore Throat):

• Pathophysiology: Inflammation of the pharynx caused by viruses (e.g., common

cold, flu) or bacteria (e.g., Streptococcus).
• Result: Swelling, pain, and difficulty swallowing.

D. Laryngitis:

• Pathophysiology: Inflammation of the larynx (voice box) caused by infection,

overuse of the voice, or exposure to irritants (e.g., smoke, allergens).
• Result: Vocal cord swelling, leading to hoarseness or loss of voice.

E. Tonsillitis:

• Pathophysiology: Inflammation of the tonsils due to viral or bacterial infection,

most commonly caused by Streptococcus.
• Result: Swelling of the tonsils, sore throat, difficulty swallowing, and possible
airway obstruction in severe cases.

2. Describe Etiologies, Signs, and Symptoms of Disorders of the Upper

Respiratory Tract:

A. Rhinitis:

• Etiologies:
o Viral (common cold), allergens (pollen, dust), irritants (smoke, pollutants), or
bacterial infections.
• Signs and Symptoms:
o Nasal congestion, runny nose, sneezing, itchy eyes, postnasal drip, mild
sore throat, and headache.
B. Sinusitis:

• Etiologies:
o Viral infections (cold), bacterial infections (Streptococcus pneumoniae,
Haemophilus influenzae), or allergies.
• Signs and Symptoms:
o Facial pain or pressure, nasal congestion, thick nasal discharge, loss of
smell, fever, and cough.

C. Pharyngitis:

• Etiologies:
o Viral (common cold, influenza), bacterial (group A Streptococcus), or
irritants (smoking, dry air).
• Signs and Symptoms:
o Sore throat, difficulty swallowing, swollen lymph nodes, fever, red or swollen
tonsils, and white patches in the throat (bacterial).

D. Laryngitis:

• Etiologies:
o Viral infections, vocal strain (yelling, singing), allergens, or irritants (smoking,
chemicals).
• Signs and Symptoms:
o Hoarseness, weak or lost voice, dry throat, cough, and sore throat.

E. Tonsillitis:

• Etiologies:
o Viral infections (Epstein-Barr virus), bacterial infections (Streptococcus
pyogenes).
• Signs and Symptoms:
o Red, swollen tonsils, white patches on tonsils, sore throat, difficulty
swallowing, fever, and swollen lymph nodes.
3. Describe Current Therapeutic Measures for Disorders of the Upper
Respiratory Tract:

A. Rhinitis:

• Medications:
o Decongestants, antihistamines, nasal corticosteroids, saline nasal sprays,
and analgesics for pain and fever.
• Supportive Care:
o Adequate hydration, rest, and humidified air.

B. Sinusitis:

• Medications:
o Antibiotics for bacterial infections, nasal decongestants, corticosteroids
(intranasal), saline nasal rinses, and pain relievers.
• Surgical Intervention:
o In cases of chronic sinusitis, functional endoscopic sinus surgery (FESS)
may be necessary to clear obstructed sinuses.

C. Pharyngitis:

• Medications:
o Antibiotics for bacterial infections (penicillin for Streptococcus), analgesics
(acetaminophen, ibuprofen), lozenges, and throat sprays.
• Supportive Care:
o Gargling with warm salt water, rest, and staying hydrated.

D. Laryngitis:

• Medications:
o Voice rest, humidified air, hydration, and corticosteroids in severe cases.
• Avoidance:
o Avoid smoking, alcohol, and vocal strain.

E. Tonsillitis:

• Medications:
 o Antibiotics for bacterial infections (e.g., amoxicillin), analgesics
(acetaminophen), and throat lozenges.
• Surgery:
o Tonsillectomy may be indicated in recurrent or chronic cases.

4. Plan Nursing Care for the Patient with an Upper Respiratory Disorder:

• Assessment:
o Assess for respiratory difficulty (rate, rhythm, and depth), throat pain, and
airway patency.
o Monitor vital signs, especially temperature and oxygen saturation (SpO2).
o Inspect for signs of infection, inflammation, or swelling.
• Interventions:
o Airway management: Keep the patient in a semi-Fowler's position to
facilitate easier breathing.
o Medication administration: Administer prescribed antibiotics, analgesics,
antihistamines, or decongestants.
o Hydration: Encourage oral fluids to thin secretions and promote mucous
clearance.
o Pain management: Administer analgesics as prescribed and recommend
throat lozenges.
o Patient education: Teach patients about hand hygiene to prevent infections
and encourage rest and hydration.

5. Discuss How You Will Know Whether Your Care Has Been Effective:

• Improvement in Symptoms:
o Decreased nasal congestion, improved breathing, reduction in pain, and less
coughing.
• Normal Vital Signs:
o Temperature normalization, absence of fever, stable respiratory rate, and
adequate oxygenation (SpO2 > 95%).
• Patient Comfort:
o Patient reports reduced discomfort, improved ability to swallow, and
reduced throat pain.
• Infection Control:
 o Absence of purulent discharge, resolution of fever, and normal appearance
of the pharynx or tonsils.

6. Identify the Special Needs of the Patient Who Has Undergone a

Laryngectomy:

• Airway Management:
o A laryngectomy results in a permanent tracheostomy, so airway clearance
and care of the stoma are crucial.
o Suctioning may be necessary to remove secretions.
• Communication:
o Provide alternative communication methods, such as writing pads,
electronic communication devices, or speech therapy for esophageal or
electronic speech techniques.
• Nutritional Support:
o Tube feeding may be required initially, and gradual reintroduction of oral
intake under the supervision of a speech therapist is essential.
• Emotional Support:
o Patients may experience feelings of loss and isolation due to changes in
communication and appearance. Provide psychological support and refer to
support groups or counseling.
• Stoma Care:
o Instruct the patient on daily stoma care, cleaning the area around the stoma,
and how to manage the tracheostomy tube if necessary.
o Educate the patient on how to protect the stoma from water (e.g., during
showers) and irritants (e.g., dust, smoke).
• Infection Prevention:
o Ensure the patient understands the importance of keeping the stoma clean
and recognizing signs of infection.
• Long-term Care:
o Teach the patient to use a humidifier to keep secretions moist, avoid irritants
(e.g., smoke, dust), and recognize complications like stoma obstruction.
Explain the Pathophysiology of Each of the Disorders of the Lower
Respiratory Tract:

A. Chronic Obstructive Pulmonary Disease (COPD):

• Pathophysiology:
o A progressive inflammatory disease characterized by airflow limitation.
Includes emphysema (destruction of alveoli and loss of elastic recoil) and
chronic bronchitis (inflammation and excessive mucus production).
o The chronic inflammation leads to narrowing of the airways, increased
mucus production, and structural changes in the lung tissue.

B. Asthma:

• Pathophysiology:
o A chronic inflammatory disorder of the airways resulting in hyper-
responsiveness, airway obstruction, and bronchoconstriction.
o Exposure to allergens, irritants, or respiratory infections leads to
inflammation, mucus production, and tightening of the smooth muscle
around the airways.

C. Pneumonia:

• Pathophysiology:
o An infection of the lung parenchyma, leading to inflammation of the alveoli.
Pathogens (bacteria, viruses, fungi) invade the alveoli, causing fluid and
inflammatory cells to accumulate.
o This results in impaired gas exchange due to consolidation and reduced
surface area for oxygen diffusion.

D. Pulmonary Embolism (PE):

• Pathophysiology:
o A blockage of a pulmonary artery by a thrombus (blood clot) or other
material. This obstruction reduces blood flow to the affected lung area,
leading to hypoxemia and potential infarction of lung tissue.
 o It triggers a compensatory response, increasing respiratory rate to maintain
oxygen levels.

E. Interstitial Lung Disease (ILD):

• Pathophysiology:
o A group of disorders characterized by inflammation and scarring (fibrosis) of
the lung interstitium. This leads to stiffness of the lung tissue, affecting the
ability to expand and contract effectively.
o Causes include long-term exposure to hazardous materials, autoimmune
diseases, and certain medications.

2. Describe the Etiologies, Signs, and Symptoms of Each of the Disorders:

A. Chronic Obstructive Pulmonary Disease (COPD):

• Etiologies:
o Smoking (primary cause), exposure to pollutants, occupational dust and
chemicals, genetic factors (e.g., alpha-1 antitrypsin deficiency).
• Signs and Symptoms:
o Chronic cough, sputum production, dyspnea (shortness of breath),
wheezing, and frequent respiratory infections.

B. Asthma:

• Etiologies:
o Allergens (pollen, pet dander), respiratory infections, exercise, smoke, cold
air, and stress.
• Signs and Symptoms:
o Wheezing, chest tightness, cough (especially at night or early morning), and
difficulty breathing.

C. Pneumonia:

• Etiologies:
o Bacterial (Streptococcus pneumoniae), viral (influenza, RSV), fungal
infections, and aspiration of food or liquids.
 • Signs and Symptoms:
o Cough (productive or dry), fever, chills, pleuritic chest pain, difficulty
breathing, fatigue, and crackles on auscultation.

D. Pulmonary Embolism (PE):

• Etiologies:
o Deep vein thrombosis (DVT) in the legs, surgery, prolonged immobility,
certain medical conditions (e.g., cancer, heart disease), and
hypercoagulable states.
• Signs and Symptoms:
o Sudden onset dyspnea, chest pain (sharp and worsens with breathing),
tachycardia, cough (may produce blood), and anxiety.

E. Interstitial Lung Disease (ILD):

• Etiologies:
o Exposure to asbestos, silica, coal dust, autoimmune diseases (e.g.,
rheumatoid arthritis, scleroderma), and certain medications (e.g.,
chemotherapy agents).
• Signs and Symptoms:
o Progressive dyspnea, dry cough, fatigue, weight loss, and clubbing of fingers.

3. Identify Tests That Are Used to Diagnose Lower Respiratory Disorders:

• Pulmonary Function Tests (PFTs): Measure lung volumes, capacities, and airflow
to assess for obstructive or restrictive patterns.
• Chest X-ray: Helps visualize abnormalities in the lungs, such as pneumonia,
masses, or signs of COPD.
• Computed Tomography (CT) Scan: Provides detailed images of lung structures
and can identify pulmonary embolisms or interstitial lung disease.
• Arterial Blood Gas (ABG): Assesses oxygen and carbon dioxide levels, as well as
acid-base balance.
• Sputum Culture: Identifies pathogens causing respiratory infections (bacterial,
viral, fungal).
• Bronchoscopy: Allows direct visualization of the airways, biopsy, or collection of
secretions.
 • Ventilation-Perfusion (V/Q) Scan: Assesses blood flow and ventilation in the lungs
to diagnose pulmonary embolism.

4. Describe Therapeutic Measures Used for Disorders of the Lower

Respiratory Tract:

A. Chronic Obstructive Pulmonary Disease (COPD):

• Medications:
o Bronchodilators (short-acting and long-acting), inhaled corticosteroids,
phosphodiesterase-4 inhibitors, and antibiotics for exacerbations.
• Oxygen Therapy: To maintain adequate oxygen saturation levels.
• Pulmonary Rehabilitation: A program that includes exercise training, nutritional
counseling, and education on disease management.

B. Asthma:

• Medications:
o Quick-relief medications (short-acting beta-agonists) for acute symptoms,
long-term control medications (inhaled corticosteroids, leukotriene
modifiers).
• Avoidance of Triggers: Education on avoiding allergens and irritants.
• Asthma Action Plan: Developing a plan for managing asthma symptoms and
medication use.

C. Pneumonia:

• Medications:
o Antibiotics for bacterial pneumonia, antiviral medications for viral
pneumonia, and supportive care (hydration, analgesics).
• Respiratory Support: Supplemental oxygen, nebulized bronchodilators if wheezing
is present.

D. Pulmonary Embolism (PE):

• Medications:
 o Anticoagulants (heparin, warfarin) to prevent further clotting and
thrombolytics in severe cases.
• Supportive Care: Oxygen therapy and analgesics for pain management.

E. Interstitial Lung Disease (ILD):

• Medications:
o Corticosteroids to reduce inflammation, antifibrotic agents (e.g.,
pirfenidone), and oxygen therapy.
• Supportive Care: Pulmonary rehabilitation and palliative care for symptom
management.

5. List Data to Collect When Caring for Patients with Disorders of the
Lower Respiratory Tract:

• Health History:
o History of respiratory diseases, smoking history, occupational exposures,
and family history.
• Symptoms:
o Assess for cough (productive or non-productive), sputum color and
consistency, shortness of breath, chest pain, and wheezing.
• Physical Assessment:
o Respiratory rate, depth, and use of accessory muscles.
o Oxygen saturation levels (SpO2) and arterial blood gas (ABG) values if
available.
• Vital Signs:
o Temperature (to assess for infection), heart rate, and blood pressure.
• Lab and Diagnostic Test Results:
o Review results from PFTs, chest X-ray, CT scans, sputum cultures, and any
other relevant tests.

6. Plan Nursing Care for Patients with Disorders of the Lower Respiratory
Tract:

• Assessment:
 o Monitor respiratory rate, depth, and effort. Assess lung sounds for
abnormalities (wheezing, crackles).
o Evaluate oxygen saturation and document changes.
• Interventions:
o Airway Management: Encourage deep breathing exercises, use of incentive
spirometry, and positioning to optimize lung expansion.
o Medications: Administer bronchodilators, corticosteroids, or antibiotics as
prescribed and educate the patient about their use.
o Hydration: Encourage fluid intake to help thin secretions.
o Education: Teach about recognizing worsening symptoms, importance of
adherence to treatment, and smoking cessation.

7. Identify Interventions for Patients Experiencing Impaired Gas

Exchange, Ineffective Airway Clearance, or Ineffective Breathing Pattern:

Impaired Gas Exchange:

• Position the patient in an upright or semi-Fowler's position to enhance lung

expansion.
• Administer oxygen therapy as prescribed and monitor SpO2 levels.
• Encourage deep breathing exercises to promote alveolar expansion.

Ineffective Airway Clearance:

• Encourage fluid intake to thin secretions.

• Teach and assist with effective coughing techniques (huff coughing).
• Administer bronchodilators or mucolytics as prescribed.
• Consider chest physiotherapy or postural drainage to help clear secretions.

Ineffective Breathing Pattern:

• Monitor the patient’s respiratory pattern and provide supplemental oxygen as

needed.
• Assist with pursed-lip breathing techniques to promote better ventilation.
• Teach relaxation techniques to reduce anxiety and promote more effective
breathing.
8. Explain How You Will Know Whether Your Nursing Interventions Have
Been Effective:

• Improvement in Respiratory Status:

o Increased oxygen saturation (SpO2 > 92% or as prescribed), improved lung
sounds (reduction in wheezing or crackles), and improved respiratory rate
and effort.
• Enhanced Airway Clearance:
o Reduction in cough frequency, clear or reduced sputum production, and
patient-reported ease of breathing.
• Stable Vital Signs:
o Normalization of respiratory rate, heart rate, and temperature, indicating
effective management of symptoms.
• Patient Understanding:
o Patient can verbalize understanding of medication regimen, breathing
techniques, and when to seek medical attention.
• Absence of Complications:
o No signs of respiratory distress, infection, or exacerbation of symptoms
during the hospital stay or follow-up visits.

Identify the Normal Anatomy of the Cardiovascular System:

The cardiovascular system consists of the heart, blood vessels, and blood.

• Heart:
o Chambers:
▪ Atria: The right atrium receives deoxygenated blood from the body via
the superior and inferior vena cavae, while the left atrium receives
oxygenated blood from the lungs via the pulmonary veins.
▪ Ventricles: The right ventricle pumps deoxygenated blood to the
lungs via the pulmonary artery, and the left ventricle pumps
oxygenated blood to the body via the aorta.
o Valves:
▪ Atrioventricular (AV) Valves: The tricuspid valve (right side) and
mitral valve (left side) prevent backflow into the atria during
ventricular contraction.
 ▪ Semilunar Valves: The pulmonary valve (between the right ventricle
and pulmonary artery) and aortic valve (between the left ventricle and
aorta) prevent backflow into the ventricles.
• Blood Vessels:
o Arteries: Carry oxygenated blood away from the heart (except the pulmonary
arteries).
o Veins: Carry deoxygenated blood back to the heart (except the pulmonary
veins).
o Capillaries: Microscopic vessels where gas, nutrient, and waste exchange
occurs between blood and tissues.

2. Explain the Normal Function of the Cardiovascular System:

• Circulation:
o Systemic Circulation: Transports oxygenated blood from the left ventricle
through the aorta to the body and returns deoxygenated blood to the right
atrium.
o Pulmonary Circulation: Carries deoxygenated blood from the right ventricle
to the lungs for oxygenation and returns oxygenated blood to the left atrium.
• Oxygen and Nutrient Delivery: The cardiovascular system ensures the delivery of
oxygen and nutrients to tissues and organs while removing carbon dioxide and
metabolic waste.
• Hormonal and Temperature Regulation: The system helps regulate body
temperature and distributes hormones throughout the body.
• Fluid Balance: Maintains fluid and electrolyte balance through the circulatory
system's connection with the kidneys and lymphatic system.

3. List Data to Collect When Caring for a Patient with a Disorder of the
Cardiovascular System:

• Health History:
o History of cardiovascular diseases (hypertension, coronary artery disease,
heart failure), family history, lifestyle factors (smoking, diet, exercise), and
medications.
• Symptoms:
o Chest pain (character, location, duration), dyspnea (difficulty breathing),
palpitations, fatigue, edema, syncope (fainting), and cough.
• Physical Examination:
 o Vital signs (blood pressure, heart rate, respiratory rate, temperature),
auscultation of heart sounds (S1, S2, any murmurs), assessment of
peripheral pulses, and presence of edema.
• Diagnostic Test Results:
o Review lab results (lipid panel, electrolytes, cardiac enzymes, and B-type
natriuretic peptide [BNP]) and previous diagnostic test results.

4. Identify Tests Commonly Performed to Diagnose Disorders of the

Cardiovascular System:

• Electrocardiogram (ECG or EKG): Records the electrical activity of the heart and
detects arrhythmias, ischemia, and other abnormalities.
• Echocardiogram: Ultrasound of the heart to evaluate structure, function, and
blood flow.
• Stress Testing: Assesses cardiovascular response to exercise or pharmacologic
stress.
• Chest X-ray: Visualizes the size and shape of the heart and lungs, helping to identify
heart failure or other abnormalities.
• Cardiac Catheterization: Involves threading a catheter through blood vessels to
the heart to assess coronary arteries, measure pressures, and evaluate heart
function.
• Blood Tests:
o Cardiac Markers (e.g., troponin, CK-MB) to detect myocardial injury.
o Lipid Profile to assess cholesterol levels.
o B-type Natriuretic Peptide (BNP) to evaluate heart failure.

5. Plan Nursing Care for Patients Undergoing Diagnostic Tests for

Cardiovascular Disorders:

• Pre-Test Care:
o Obtain informed consent for procedures (e.g., cardiac catheterization).
o Assess the patient's understanding and provide education on what to expect
during the test.
o Ensure fasting as required (e.g., for lipid panels or certain imaging tests).
o Monitor vital signs and assess for allergies (e.g., to contrast dye).
• Post-Test Care:
o Monitor vital signs for any changes post-procedure.
 o Assess the insertion site for bleeding or hematoma if applicable (e.g., after
cardiac catheterization).
o Provide comfort measures and hydration as needed.
o Educate the patient on activity restrictions or follow-up appointments.

6. Describe Current Therapeutic Measures for Disorders of the

Cardiovascular System:

• Lifestyle Modifications:
o Dietary changes (e.g., DASH diet, low-sodium diet), smoking cessation,
weight management, and regular exercise.
• Medications:
o Antihypertensives (ACE inhibitors, beta-blockers, diuretics) for
hypertension.
o Antiplatelet Agents (aspirin, clopidogrel) for coronary artery disease
prevention.
o Anticoagulants (warfarin, direct oral anticoagulants) for thromboembolism
prevention.
o Statins for lipid management.
o Heart Failure Medications (diuretics, ACE inhibitors, beta-blockers) to
manage symptoms.
• Surgical Interventions:
o Coronary Artery Bypass Grafting (CABG) for severe coronary artery
disease.
o Percutaneous Coronary Intervention (PCI) for blocked coronary arteries.
o Valve Repair or Replacement for valvular heart disease.

7. Describe Preoperative and Postoperative Care for Patients Undergoing

Cardiac Surgery:

Preoperative Care:

• Assessment:
o Complete health assessment, including cardiac and respiratory function.
• Education:
o Explain the procedure, risks, and postoperative expectations.
• Preoperative Testing:
 o Complete necessary lab work, ECG, and imaging studies.
• Medication Management:
o Review medications; hold anticoagulants or other medications as per
protocol.
• Emotional Support:
o Provide reassurance and support to reduce anxiety.

Postoperative Care:

• Monitoring:
o Vital signs (especially heart rate and blood pressure), cardiac rhythm, and
oxygen saturation.
o Monitor for complications (e.g., bleeding, infection, arrhythmias).
• Pain Management:
o Administer prescribed analgesics and assess pain regularly.
• Mobility:
o Encourage early ambulation as tolerated to prevent complications (e.g.,
venous thromboembolism).
• Patient Education:
o Instruct on wound care, activity restrictions, and medication management
post-discharge.
• Follow-Up:
o Schedule follow-up appointments for cardiac rehabilitation and ongoing
monitoring.

Valvular Disorders

Pathophysiology:

Valvular heart diseases involve the malfunction of one or more heart valves, affecting
blood flow through the heart. The main types are:

• Stenosis: Narrowing of the valve opening, which restricts blood flow.

• Regurgitation: Incomplete closure of the valve, allowing blood to flow backward.

Etiology:

• Rheumatic Fever: A complication of streptococcal throat infection.

 • Degenerative Changes: Aging, calcification, or congenital defects.
• Infective Endocarditis: Infection of the heart valves.

Signs and Symptoms:

• Stenosis: Dyspnea, fatigue, angina, syncope, and heart murmurs.

• Regurgitation: Symptoms of heart failure, such as shortness of breath,
palpitations, and swelling.

Diagnostic Tests:

• Echocardiogram: To assess valve structure and function.

• Chest X-ray: To visualize heart size and shape.
• Electrocardiogram (ECG): To check for arrhythmias.
• Cardiac Catheterization: For hemodynamic assessment.

Therapeutic Measures:

• Medications: Diuretics, beta-blockers, ACE inhibitors, and anticoagulants.

• Surgery:
o Commissurotomy: Surgical widening of the valve opening.
o Annuloplasty: Repair of the valve annulus to improve function.
o Valve Replacement: Replacing a damaged valve with a mechanical or
biological valve.

Nursing Care:

• Assess vital signs, including heart sounds and rhythm.

• Monitor for signs of heart failure.
• Educate patients about lifestyle modifications and medication adherence.
• Postoperatively, monitor for complications and provide wound care.

2. Comparison of Surgical Procedures:

Procedure Indication Outcomes Risks

 Valvular Improves blood flow;
Risk of bleeding, infection,
Commissurotomy stenosis (e.g., preserves valve
valve regurgitation
mitral stenosis) function
Mitral or Tightens the valve Similar to
Annuloplasty tricuspid annulus to reduce commissurotomy; may
regurgitation regurgitation still need replacement
Replacement Risk of valve dysfunction,
Valve Severe stenosis
restores normal thromboembolism, and
Replacement or regurgitation
blood flow endocarditis

3. Postoperative Complications Following Cardiac Valve Replacement:

• Thromboembolism: Clots can form on the prosthetic valve.

• Infective Endocarditis: Increased risk of infection on the new valve.
• Heart Failure: Due to continued cardiac dysfunction.
• Arrhythmias: Potentially caused by surgical trauma to the heart.
• Wound Complications: Infection or poor healing at the surgical site.

4. Infective Endocarditis

Pathophysiology:

Infective endocarditis is an infection of the inner lining of the heart, often affecting the
heart valves. It results from the colonization of bacteria or fungi, leading to vegetation
formation, valve destruction, and systemic embolization.

Etiology:

• Bacterial infections (e.g., Streptococcus, Staphylococcus)

• Fungal infections (e.g., Candida)
• Risk factors include prosthetic heart valves, congenital heart defects, and previous
endocarditis.

Signs and Symptoms:

• Fever, chills, and night sweats

 • Fatigue and malaise
• Heart murmur
• Petechiae (small red or purple spots on the skin)
• Osler nodes (painful lesions on fingers/toes)
• Janeway lesions (painless spots on palms/soles)

Diagnostic Tests:

• Blood Cultures: To identify causative organisms.

• Echocardiogram: To visualize vegetations on valves.
• Complete Blood Count (CBC): To check for anemia and infection.

Therapeutic Measures:

• Antibiotic Therapy: IV antibiotics for several weeks based on culture results.

• Surgery: Valve repair or replacement in severe cases.

Nursing Care:

• Monitor vital signs and for signs of systemic embolization.

• Administer medications as prescribed.
• Educate patients about oral hygiene and the importance of prophylactic antibiotics
before dental procedures.

5. Pericarditis

Pathophysiology:

Pericarditis is the inflammation of the pericardium, which can lead to fluid accumulation
(pericardial effusion) and restrict heart movement.

Etiology:

• Viral infections (e.g., Coxsackievirus)

• Bacterial infections
• Autoimmune diseases (e.g., lupus)
• Post-myocardial infarction (Dressler syndrome)
Signs and Symptoms:

• Sharp, pleuritic chest pain that improves when sitting forward

• Fever, fatigue, and dyspnea
• Pericardial friction rub (a scratching sound heard on auscultation)

Diagnostic Tests:

• ECG: Shows diffuse ST-segment elevation.

• Echocardiogram: To assess fluid accumulation.
• Chest X-ray: To visualize the silhouette of the heart.

Therapeutic Measures:

• NSAIDs: For pain relief.

• Corticosteroids: For severe inflammation.
• Pericardiocentesis: To drain excess fluid if necessary.

Nursing Care:

• Assess chest pain and vital signs regularly.

• Educate on medication adherence and activity modification.
• Monitor for signs of complications, such as cardiac tamponade.

6. Myocarditis

Pathophysiology:

Myocarditis is the inflammation of the myocardium, leading to myocardial damage,

dysfunction, and potentially heart failure.

Etiology:

• Viral infections (e.g., influenza, adenovirus)

• Bacterial infections
• Autoimmune disorders
Signs and Symptoms:

• Chest pain, fatigue, and shortness of breath

• Heart palpitations or arrhythmias
• Signs of heart failure (e.g., edema, jugular venous distension)

Diagnostic Tests:

• ECG: May show arrhythmias or ST changes.

• Echocardiogram: To assess ventricular function.
• Endomyocardial Biopsy: May be performed to confirm diagnosis.

Therapeutic Measures:

• Supportive Care: Managing heart failure symptoms.

• Immunosuppressive Therapy: In cases related to autoimmune diseases.
• Antiviral or Antibiotic Therapy: If infectious etiology is identified.

Nursing Care:

• Monitor vital signs and heart rhythm.

• Educate on recognizing symptoms of heart failure.
• Provide emotional support and education on long-term management.

7. Cardiomyopathies

Dilated Cardiomyopathy:

• Pathophysiology: Characterized by ventricular dilation and impaired contractility.

• Etiology: Idiopathic, alcohol abuse, infections, genetic factors.
• Signs and Symptoms: Heart failure symptoms, fatigue, arrhythmias.
• Diagnostic Tests: Echocardiogram, MRI, cardiac catheterization.
• Therapeutic Measures: Heart failure management, potential heart transplant.
• Nursing Care: Monitor for heart failure signs and educate on lifestyle changes.
Hypertrophic Cardiomyopathy:

• Pathophysiology: Abnormal thickening of the heart muscle, leading to obstruction.

• Etiology: Genetic mutations, often familial.
• Signs and Symptoms: Dyspnea, chest pain, syncope, arrhythmias.
• Diagnostic Tests: Echocardiogram, ECG.
• Therapeutic Measures: Medications to reduce symptoms, septal myectomy or
alcohol septal ablation in severe cases.
• Nursing Care: Educate on activity restrictions and recognize symptoms of
arrhythmias.

Restrictive Cardiomyopathy:

• Pathophysiology: Stiffening of the ventricular walls, limiting filling during diastole.

• Etiology: Amyloidosis, sarcoidosis, fibrosis.
• Signs and Symptoms: Signs of heart failure, exercise intolerance, edema.
• Diagnostic Tests: Echocardiogram, MRI, endomyocardial biopsy.
• Therapeutic Measures: Symptom management; heart transplant may be
considered.
• Nursing Care: Monitor for heart failure symptoms and provide dietary education.

8. Thrombophlebitis

Pathophysiology:

Thrombophlebitis involves inflammation of a vein with associated thrombosis, often in

superficial veins.

Etiology:

• Prolonged immobility
• Varicose veins
• Venous stasis
• Trauma or injury to a vein
Signs and Symptoms:

• Redness and swelling along the affected vein

• Pain or tenderness in the area
• Possible warmth over the site

Complications:

• Deep vein thrombosis (DVT)

• Pulmonary embolism (PE)

Diagnostic Tests:

• Ultrasound: To assess blood flow and detect clots.

• D-dimer: Elevated levels may indicate thrombosis.

Therapeutic Measures:

• NSAIDs: For pain relief.

• Compression stockings: To reduce swelling and promote venous return.
• Anticoagulation Therapy: In cases at risk for DVT or PE.

Nursing Care:

• Monitor for signs of complications (e.g., swelling, changes in skin color).

• Educate patients on leg elevation and compression use.
• Promote mobility as tolerated to prevent further thrombosis.

Coronary Artery Disease (CAD)

Etiology:

• Atherosclerosis: The most common cause, characterized by the buildup of fatty

deposits (plaques) in the coronary arteries.
• Risk Factors: High cholesterol, hypertension, smoking, diabetes, obesity,
sedentary lifestyle, age, and family history.
Signs and Symptoms:

• Asymptomatic: Many patients may not show symptoms until significant narrowing
occurs.
• Chest Pain: Pressure or squeezing in the chest.
• Shortness of Breath: Especially during physical activity.
• Fatigue: Often noted during exertion.

Therapeutic Measures:

• Lifestyle Modifications: Diet, exercise, smoking cessation.

• Medications:
o Antiplatelets: Aspirin or clopidogrel to prevent clot formation.
o Statins: To lower cholesterol levels.
o Beta-blockers: To reduce heart workload.
o ACE inhibitors: To manage blood pressure.
• Surgical Interventions:
o Angioplasty and Stenting: To open narrowed arteries.
o Coronary Artery Bypass Grafting (CABG): Bypass blocked arteries.

2. Angina Pectoris

Etiology:

• Myocardial Ischemia: Occurs when the heart muscle does not receive enough
oxygen-rich blood, often due to CAD.
• Triggers: Physical exertion, emotional stress, heavy meals, or cold weather.

Signs and Symptoms:

• Chest Pain: Often described as squeezing, pressure, or tightness.

• Radiating Pain: May radiate to the arms, back, neck, or jaw.
• Shortness of Breath: Accompanying the pain.
• Nausea or Sweating: Can occur during episodes.

Therapeutic Measures:

• Medications:
 o Nitrates: To relieve angina by dilating blood vessels.
o Beta-blockers: To reduce heart rate and workload.
o Calcium Channel Blockers: To improve blood flow.
• Lifestyle Changes: Diet and exercise.
• Surgical Interventions: Similar to CAD treatments (angioplasty, CABG).

3. Myocardial Infarction (MI)

Etiology:

• Coronary Thrombosis: Most commonly due to a rupture of an atherosclerotic

plaque leading to blood clot formation in a coronary artery.
• Risk Factors: Same as for CAD.

Signs and Symptoms:

• Chest Pain: Severe, often described as a "crushing" or "squeezing" feeling.

• Radiating Pain: Similar to angina, but more intense.
• Shortness of Breath: May occur at rest or with activity.
• Other Symptoms: Sweating, nausea, vomiting, anxiety, and fainting.

Therapeutic Measures:

• Medications:
o Aspirin: To prevent further clotting.
o Thrombolytics: To dissolve blood clots.
o Antiplatelet agents: Such as clopidogrel.
o Beta-blockers, ACE inhibitors, and statins: Similar to CAD treatment.
• Surgical Interventions:
o Angioplasty and Stenting: Immediate intervention.
o CABG: For severe cases.

Data Collection for CAD, Angina Pectoris, or MI:

• Patient History: Family history of heart disease, risk factors, lifestyle habits.
• Physical Examination: Vital signs, heart sounds, respiratory status.
• Symptoms: Onset, duration, and characteristics of chest pain.
 • Diagnostic Tests:
o ECG: To assess for ischemia or infarction.
o Cardiac Enzymes: Elevated troponin or CK-MB levels in MI.
o Echocardiogram: To assess heart function.
o Stress Tests: To evaluate exercise tolerance and ischemic changes.

Peripheral Vascular Disorders

Etiology:

• Atherosclerosis: The leading cause of peripheral arterial disease (PAD).

• Venous Disorders: Such as venous thromboembolism and chronic venous
insufficiency.
• Risk Factors: Smoking, diabetes, hypertension, hyperlipidemia, and obesity.

Signs and Symptoms:

• Peripheral Arterial Disease (PAD):

o Claudication (pain in legs during activity).
o Weak or absent pulses in the legs.
o Coldness or color changes in the legs.
o Non-healing wounds or ulcers.
• Venous Insufficiency:
o Swelling in the legs.
o Aching or heaviness in the legs.
o Varicose veins.
o Skin changes (thickening, discoloration).

Therapeutic Measures:

• Lifestyle Modifications: Smoking cessation, exercise, diet changes.

• Medications:
o Antiplatelets: Aspirin or clopidogrel for PAD.
o Statins: To manage cholesterol.
o Anticoagulants: For venous disorders.
• Surgical Interventions:
o Angioplasty or Stenting: For PAD.
 o Vein Stripping or Sclerotherapy: For varicose veins.

Nursing Care for Patients with Peripheral Vascular Disorders:

• Assessment: Monitor vital signs, assess peripheral pulses, and check for signs of
ischemia or venous insufficiency.
• Education: Teach patients about lifestyle changes, medication adherence, and
wound care.
• Activity: Encourage safe mobility and leg elevation to reduce swelling.
• Monitoring: Watch for complications such as skin breakdown or signs of clot
formation.